Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Botswana Tenofovir Oral HIV Prophylaxis Trial

This study has been terminated.
(Consenting participants entered tenofovir/emtricitabine oral prophylaxis trial)
Sponsor:
Collaborators:
Botswana Ministry of Health
Gilead Sciences
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00111150
First received: May 17, 2005
Last updated: March 16, 2007
Last verified: March 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2007
  Estimated Primary Completion Date: No date given